Keyphrases
Novel Biomarkers
100%
Lupus-prone Mice
100%
Biomarker Discovery
100%
Mouse Serum
100%
Comprehensive Proteomic Analysis
100%
Systemic Lupus Erythematosus
66%
Renal Disease
66%
MDCs
66%
Serum Proteome
66%
Reinforced
33%
Interleukin-6
33%
Serum Levels
33%
Enrichment Analysis
33%
Patient Care
33%
Path Analysis
33%
Mouse Model
33%
IP-10
33%
Interleukin-17 (IL-17)
33%
Monocyte Chemoattractant protein-1 (MCP-1)
33%
Interleukin-10
33%
Lupus
33%
Non-invasive Biomarkers
33%
Lymphoproliferative Disorders
33%
Lupus Nephritis
33%
Organ Pathology
33%
Protein Level
33%
Vascular Cell Adhesion molecule-1 (VCAM-1)
33%
New Biomarkers
33%
Biological Relevance
33%
ELISA Validation
33%
Murine Lupus Model
33%
Clinical Investigation
33%
Human Pathology
33%
Proteomic Screening
33%
Screening Strategy
33%
Cytokine Signaling
33%
Organ-specific
33%
Lupus-like Disease
33%
Therapeutic Study
33%
L-selectin
33%
Platelet-derived Growth Factor Receptor (PDGFR)
33%
Biomarker Candidates
33%
CXCL13
33%
Immune Cell Migration
33%
Serum Proteomics
33%
TNFRI
33%
Protein Enrichment
33%
Mechanistic Studies
33%
Adult Female
33%
Fold Increase
33%
Lupus Biomarkers
33%
Biochemistry, Genetics and Molecular Biology
Biomarker Discovery
100%
Proteomics
100%
Mouse
100%
Proteome
66%
Mouse Model
33%
Interleukin-6
33%
Cell Migration
33%
Immunocompetent Cell
33%
Blood Level
33%
CXCL13
33%
Cytokine
33%
Interleukin 17
33%
VCAM-1
33%
L-Selectin
33%
Thymic Stromal Lymphopoietin
33%
Immunology and Microbiology
Lupus Erythematosus
100%
Mouse
100%
Systemic Lupus Erythematosus
28%
Interleukin 17
14%
Interleukin-6
14%
Cytokine Signaling
14%
Thymic Stromal Lymphopoietin
14%
Immunocompetent Cell
14%
Mouse Model
14%
ELISA
14%
Blood Level
14%
VCAM-1
14%
L-Selectin
14%
CXCL13
14%
Thymus and Activation Regulated Chemokine
14%
Nephritis
14%
Cell Migration
14%
Drug-Induced Lupus Erythematosus
14%